Sirnaomics (HKSE:02257) EPS (Basic) : HK$-5.15 (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Sirnaomics EPS (Basic)?

Sirnaomics's basic earnings per share (Basic EPS) for the six months ended in Dec. 2024 was HK$-0.93. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-5.15.

Sirnaomics's EPS (Diluted) for the six months ended in Dec. 2024 was HK$-0.93. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-5.15.

Sirnaomics's EPS without NRI for the six months ended in Dec. 2024 was HK$-0.71. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was -3.07.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Sirnaomics EPS (Basic) Historical Data

The historical data trend for Sirnaomics's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirnaomics EPS (Basic) Chart

Sirnaomics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

-3.85

-111.53

-9.03

-8.04

-5.13

Sirnaomics Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EPS (Basic)	Get a 7-Day Free Trial					-4.75	-3.92	-4.14	-4.22	-0.93

Sirnaomics EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Sirnaomics's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-399.421	-	0)	/	77.470
	=	-5.16

Sirnaomics's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-80.206	-	0)	/	78.921
	=	-1.02

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-5.15

Sirnaomics (HKSE:02257) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Sirnaomics EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Sirnaomics's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Sirnaomics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirnaomics Ltd (HKSE:02257) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

V5Z:Germany

Address

No.218 Xinghu Street, Unit 415, A4 Building, Suzhou Industrial Park, Suzhou, CHN

Website

https://www.sirnaomics.com

Sirnaomics Ltd is a therapeutics biopharmaceutical company with product candidates in preclinical and clinical stages that focuses on the discovery and development of drugs for indications with medical needs and large market opportunities. The Group's operations and non-current assets are located at the United States of America and the mainland of the People's Republic of China.

Executives

Lu Yang	2101 Beneficial owner
Poon Hung Fai	2101 Beneficial owner
Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Dai Xiaochang	2201 Interest of corporation controlled by you
Yan Xia Ling	2202 Interest of your spouse
Ceng Yu	2201 Interest of corporation controlled by you
Li Jie	2201 Interest of corporation controlled by you
Li Lele	2202 Interest of your spouse
Shanghai Chongshi Enterprise Management Partnership(lp)	2101 Beneficial owner
Shenzhen Qianhai Rotating Boulder Fund Management Co.,ltd	2201 Interest of corporation controlled by you
Shenzhen Rotating Boulder Tiancheng The Second Investment Partnership (limited Partnership)	2201 Interest of corporation controlled by you
Shenzhen Rotating Boulder Tiancheng The Third Investment Partnership (limited Partnership)	2201 Interest of corporation controlled by you

Sirnaomics Headlines

No Headlines